Last Week in Medicine

Empagliflozin for HFpEF, Antibiotic Duration for UTIs in Men, Targeted Temperature after Cardiac Arrest, Normal Saline vs Balanced Solution in ICU Patients, Baricitinib and Therapeutic Anticoagulation for Hospitalized COVID-19 Patients

September 30, 2021 Stephen Jenkins, MD, Austin Rupp, MD, Brian Locke, MD Season 3 Episode 1
Last Week in Medicine
Empagliflozin for HFpEF, Antibiotic Duration for UTIs in Men, Targeted Temperature after Cardiac Arrest, Normal Saline vs Balanced Solution in ICU Patients, Baricitinib and Therapeutic Anticoagulation for Hospitalized COVID-19 Patients
Show Notes
  1. We're back after a nice relaxing summer taking care of a surge of COVID-19 patients.  To start off season 3 we decided to do a rapid review of some of the best articles over the last three months.  Dr. Brian Locke returns to help us break down some critical care papers, we talk about the miracle of SGLT-2 inhibitors, the treatment of UTIs in men, and the latest in COVID-19 literature. 



Hypothermia vs Normothermia after Cardiac Arrest

Empagliflozin for Heart Failure with Preserved EF

Antibiotic Duration for Afebrile UTIs in Men

Normal Saline vs Balanced Solution in ICU patients

Baricitinib for COVID-19

Therapeutic Anticoagulation for COVID-19














Music from Uppbeat (free for Creators!):

https://uppbeat.io/t/soundroll/dope

License code: NP8HLP5WKGKXFW2R